Neuro MR: Protocols

被引:29
作者
Mikulis, David J.
Roberts, Timothy P. L.
机构
[1] Toronto Western Hosp, Dept Med Imaging, Univ Hlth Network, Toronto, ON M5T 2S8, Canada
[2] Univ Penn, Sch Med, Dept Radiol, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
关键词
MRI; imaging protocols; neuroimaging; pulse sequences; central nervous system;
D O I
10.1002/jmri.21041
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Clinical MRI depends on a symbiosis between MR physics and clinical requirements. The imaging solutions are based on a balance between the "palette" of available image contrasts derived from nuclear spin physics and tissue biophysics, and clinical determinants such as the anticipated pathology and efficient use of imaging time. Imaging is therefore optimized to maximize diagnostic sensitivity and specificity through the development of protocols organized along the lines of major disease categories. In the other part of this two-part review, the primary determinants of image contrast, including T1, T2, and T2*, were highlighted. The development of pulse sequences designed to optimize each of these image contrasts was discussed and the impact of technological innovation (parallel imaging and high-field systems) on the manner in which these sequences could be modified to improve clinical efficacy was further emphasized. The scope of that discussion was broadened to include the application of. 1) water diffusion imaging used primarily for detection of pathologies that restrict the free movement of water in the tissues and for defining fiber tracts in the brain; 2) the intravenous administration of exogenous contrast agents (gadolinium-diethylene triamine pentaacetic acid [GdDTPA]) for assessment of blood-brain-barrier (BBB) defects and brain blood flow; and 3) MR spectroscopy (MRS) for assessment of brain metabolites. The goal of this part is to discuss how these acquisitions are combined into specific protocols that can effectively detect and characterize, or in keeping with our artistic analogy, "paint" each of the major diseases affecting the central nervous system (CNS). This work concludes with a discussion of image artifacts and pitfalls in image interpretation, which, in spite our best efforts to minimize or eliminate them, continue to occur. Much of the ensuing discussion is based on our own institutional experience. Protocols, therefore, do not necessarily match those from other institutions due to variability in clinical emphasis, MR instruments, and available software. An attempt was made to focus on basic clinical sequences that are available on most modem MR systems, with protocols employing generally accepted clinical imaging philosophies.
引用
收藏
页码:838 / 847
页数:10
相关论文
共 25 条
  • [1] Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions
    Bakshi, R
    Ariyaratana, S
    Benedict, RHB
    Jacobs, L
    [J]. ARCHIVES OF NEUROLOGY, 2001, 58 (05) : 742 - 748
  • [2] Entorhinal cortex involvement in human mesial temporal lobe epilepsy:: An electrophysiologic and volumetric study
    Bartolomei, F
    Khalil, M
    Wendling, F
    Sontheimer, A
    Régis, J
    Ranjeva, JP
    Guye, M
    Chauvel, P
    [J]. EPILEPSIA, 2005, 46 (05) : 677 - 687
  • [3] Diffusion-tensor imaging-guided tracking of fibers of the pyramidal tract combined with intraoperative cortical stimulation mapping in patients with gliomas
    Berman, JI
    Berger, MS
    Mukherjee, P
    Henry, RG
    [J]. JOURNAL OF NEUROSURGERY, 2004, 101 (01) : 66 - 72
  • [4] Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
    Brott, T
    Broderick, J
    Kothari, R
    ODonoghue, M
    Barsan, W
    Tomsick, T
    Spilker, J
    Miller, R
    Sauerbeck, L
    Farrell, J
    Kelly, J
    Perkins, T
    Miller, R
    McDonald, T
    Rorick, M
    Hickey, C
    Armitage, J
    Perry, C
    Thalinger, K
    Rhude, R
    Schill, J
    Becker, PS
    Heath, RS
    Adams, D
    Reed, R
    Klei, M
    Hughes, A
    Anthony, J
    Baudendistel, D
    Zadicoff, C
    Rymer, M
    Bettinger, I
    Laubinger, P
    Schmerler, M
    Meiros, G
    Lyden, P
    Dunford, J
    Zivin, J
    Rapp, K
    Babcock, T
    Daum, P
    Persona, D
    Brody, M
    Jackson, C
    Lewis, S
    Liss, J
    Mahdavi, Z
    Rothrock, J
    Tom, T
    Zweifler, R
    [J]. STROKE, 1997, 28 (11) : 2109 - 2118
  • [5] Characterization of brain tumors by MRS, DWI and Ki-67 labeling index
    Calvar, JA
    Meli, FJ
    Romero, C
    Yánez, ML
    Martinez, AR
    Lambre, H
    Taratuto, AL
    Sevlever, G
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2005, 72 (03) : 273 - 280
  • [6] Surveillance of intracranial aneurysms treated with detachable coils: a comparison of MRA techniques
    Farb, RI
    Nag, S
    Scott, JN
    Willinsky, RA
    Marotta, TR
    Montanera, WJ
    Tomlinson, G
    terBrugge, KG
    [J]. NEURORADIOLOGY, 2005, 47 (07) : 507 - 515
  • [7] Intracranial arteriovenous malformations: Real-time auto-triggered elliptic centric-ordered 3D gadolinium-enhanced MR angiography - Initial assessment
    Farb, RI
    McGregor, C
    Kim, JK
    Laliberte, M
    Derbyshire, JA
    Willinsky, RA
    Cooper, PW
    Westman, DG
    Cheung, G
    Schwartz, ML
    Stainsby, JA
    Wright, GA
    [J]. RADIOLOGY, 2001, 220 (01) : 244 - 251
  • [8] Filippi M, 1998, J NEUROL NEUROSUR PS, V64, pS88
  • [9] Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial
    Furlan, A
    Higashida, R
    Wechsler, L
    Gent, M
    Rowley, H
    Kase, C
    Pessin, M
    Ahuja, A
    Callahan, F
    Clark, WM
    Silver, F
    Rivera, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2003 - 2011
  • [10] Grossman RI, 1998, AM J NEURORADIOL, V19, P1251